Skip to main content
OpenTrials
Completed

NCT Number: NCT03660852

Impact of a Magnetic Resonance Imaging (MRI) Scanner Exclusively Dedicated to Emergency in the Clinical Management of Patients Presenting With Diplopia or Dizziness

IRM-DU is a prospective observational single center study conducted in an emergency department to evaluate the impact of a MRI scanner exclusively dedicated to emergency in the clinical management of patients presenting with dizziness or diplopia.

The study will compare 2 strategies : after and before availability of a MRI scanner dedicated to emergency.

The primary endpoint is the proportion of patients with a diagnosis of stroke confirmed by imaging (MRI or Computed tomography (CT)) in the group "before implementation of the emergency MRI scanner" and the group "after implementation of the emergency MRI scanner".

The hypothesis is that the availability of a MRI scanner dedicated to emergency will improve the diagnosis of stroke in patients presenting with dizziness or diplopia, and will reduce Emergency Department stay, hospital stay and hospitalisation costs.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age over 18 years
  • non opponent to participate
  • dizziness or diplopia requiring brain imaging in order to eliminate stroke

Exclusion criteria

  • opponent to participate
  • pregnant women
  • recent cerebral trauma
  • potentially eligible to thrombolysis
  • impaired consciousness
  • unable to give consent

Treatment and study plan

Primary outcomes

  1. Diagnosis is established on the positive signs of stroke highlighted on the CT scan or brain MRI according to the examination performed

    Time frame: 18 months

    Proportion of patients with a diagnosis of stroke confirmed by cerebral radiology (MRI or scan according to examination) in the pre- and post-MRI groups.

Secondary outcomes

  1. Evaluate the time of care

    Time frame: 18 months

    Evaluate the time of care: time of realization of the examination of radiology (scanner or brain MRI), delay of passage in emergencies

  2. Number of CT and brain MRI requested by the emergency physician in the before / after groups

    Time frame: 18 months

    Number of CT and brain MRI requested by the emergency physician in the before / after groups

  3. Evaluate the usual management of vertigo and diplopia

    Time frame: 18 months

    Evaluate the usual management of vertigo and diplopia: number of CT and brain MRI requested by the emergency physician in the "before / after" groups; number of cerebral CT and MRI performed by the radiologist in the "before / after" groups

  4. Evaluate the rate of new consultations in emergencies

    Time frame: 18 months

    Evaluate the rate of new consultations in emergencies for a neurological reason in the month following the initial care in emergencies, and the rate of new hospitalizations for the same reason

  5. Rate of new emergency department visits for neurological

    Time frame: the month following initial emergency care

    Rate of new emergency department visits for neurological reasons in the month following initial emergency care

  6. Evaluate the irradiation rate

    Time frame: 18 months

    Evaluate the irradiation rate related to the initial radiological examination performed during emergency care

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: IRM-DU

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Sep 7, 2018
Registry last updated
Jul 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.